Azintuxizumab (Anti-SLAMF7 / CS1)
Azintuxizumab (Anti-SLAMF7 / CS1) (A3061-GRP)
Products
Description
Azintuxizumab (Anti-SLAMF7 / CS1/ CD319/ CRACC) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A3061 |